Inogen Inc Stock Today
| INGN Stock | USD 9.52 0.32 3.25% |
PerformanceWeak
| Odds Of DistressLow
|
Inogen is selling at 9.52 as of the 25th of February 2025; that is 3.25 percent decrease since the beginning of the trading day. The stock's open price was 9.84. Inogen has less than a 16 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 25th of February 2025. Click here to learn more.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 23.9 M outstanding shares of which 798.64 K shares are currently shorted by private and institutional investors with about 3.16 trading days to cover. More on Inogen Inc
Moving against Inogen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Inogen Stock Highlights
Inogen Inc (INGN) is traded on NASDAQ Exchange in USA. It is located in 859 Ward Drive, Goleta, CA, United States, 93111 and employs 834 people. Inogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 235.21 M. Inogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 23.9 M outstanding shares of which 798.64 K shares are currently shorted by private and institutional investors with about 3.16 trading days to cover.
Inogen Inc currently holds about 223.62 M in cash with (3.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership AllocationInogen Inc has a total of 23.9 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Inogen Ownership Details
Inogen Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Inogen market risk premium is the additional return an investor will receive from holding Inogen long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0157 | |||
| Jensen Alpha | 0.0228 | |||
| Total Risk Alpha | 0.0034 | |||
| Sortino Ratio | 0.0066 |
Inogen Stock Against Markets
Inogen Corporate Management
| Nabil Shabshab | Pres CEO | Profile | |
| Vijay Paliwal | Senior Enablement | Profile | |
| Adrien Mithalal | Senior Development | Profile | |
| Agnes Lee | VP Planning | Profile | |
| Philip Corrin | Senior Chain | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.